BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 29554138)

  • 1. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    Ashhurst AS; Parumasivam T; Chan JGY; Lin LCW; Flórido M; West NP; Chan HK; Britton WJ
    PLoS One; 2018; 13(3):e0194620. PubMed ID: 29554138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.
    Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X
    Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against
    Ullah N; Hao L; Wu Y; Zhang Y; Lei Q; Banga Ndzouboukou JL; Lin X; Fan X
    J Immunol Res; 2020; 2020():2083793. PubMed ID: 32953889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
    Kao FF; Mahmuda S; Pinto R; Triccas JA; West NP; Britton WJ
    PLoS One; 2012; 7(5):e34991. PubMed ID: 22567094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice.
    Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B
    Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
    Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
    Front Immunol; 2020; 11():575504. PubMed ID: 33117374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll like-receptor agonist Pam
    Kennerknecht K; Noschka R; Löffler F; Wehrstedt S; Pedersen GK; Mayer D; Grieshober M; Christensen D; Stenger S
    Med Microbiol Immunol; 2020 Apr; 209(2):163-176. PubMed ID: 32020284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.
    Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP
    Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against
    Tian M; Zhou Z; Tan S; Fan X; Li L; Ullah N
    Front Immunol; 2018; 9():310. PubMed ID: 29535714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
    Thakur A; Ingvarsson PT; Schmidt ST; Rose F; Andersen P; Christensen D; Foged C
    Vaccine; 2018 May; 36(23):3331-3339. PubMed ID: 29699790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.
    Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A
    Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationalized design of a mucosal vaccine protects against
    Ahmed M; Jiao H; Domingo-Gonzalez R; Das S; Griffiths KL; Rangel-Moreno J; Nagarajan UM; Khader SA
    J Leukoc Biol; 2017 Jun; 101(6):1373-1381. PubMed ID: 28258153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
    Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
    Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis.
    Verwaerde C; Debrie AS; Dombu C; Legrand D; Raze D; Lecher S; Betbeder D; Locht C
    Vaccine; 2014 Oct; 32(47):6240-50. PubMed ID: 25252198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against
    Jong RM; Van Dis E; Berry SB; Nguyenla X; Baltodano A; Pastenkos G; Xu C; Fox D; Yosef N; McWhirter SM; Stanley SA
    J Immunol; 2022 Jan; 208(2):407-419. PubMed ID: 34965963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection.
    Trentini MM; de Oliveira FM; Gaeti MP; Batista AC; Lima EM; Kipnis A; Junqueira-Kipnis AP
    Vaccine; 2014 Jul; 32(34):4324-32. PubMed ID: 24951861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.